van Hall, T., André, P., Horowitz, A., Ruan, D. F., Borst, L., Zerbib, R., . . . Vivier, E. (2019). Monalizumab: Inhibiting the novel immune checkpoint NKG2A. J Immunother Cancer.
Citação norma Chicagovan Hall, Thorbald, Pascale André, Amir Horowitz, Dan Fu Ruan, Linda Borst, Robert Zerbib, Emilie Narni-Mancinelli, Sjoerd H. van der Burg, and Eric Vivier. "Monalizumab: Inhibiting the Novel Immune Checkpoint NKG2A." J Immunother Cancer 2019.
ציטוט MLAvan Hall, Thorbald, et al. "Monalizumab: Inhibiting the Novel Immune Checkpoint NKG2A." J Immunother Cancer 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.